How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

277 results for

First Aid Travel Kit

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. Policies to support practice areas caring for neonates, children and young people

to attend or inform their manager. Booking travel arrangements This policy informs the employee how to make travel arrangements to ensure the most effective use of the orgnisation’s resources. Breastfeeding staff support This policy provides information for staff who are breastfeeding, regarding the orgnisation’s commitments to, and provision for, breastfeeding mothers when they return to work. Career breaks This policy supports staff wishing to undertake a break in employment for personal or domestic

2014 Royal College of Nursing

122. Skyborn: In-flight Emergency Births on Commercial Airlines. (Abstract)

emergency births are infrequent but not trivial. Commercial airlines are dependent on physicians and other medically trained passengers to help with in-flight deliveries. Despite FAA (U.S. Federal Aviation Authority) and JAA (Joint Aviation Authority) standards, on board medical and First Aid kits are depleted and inadequate for in-flight deliveries.© International Society of Travel Medicine 2019. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail

2019 Journal of Travel Medicine

123. Clinical Guidelines and Integrated Care Pathways for the Oral Health Care of People with Learning Disabilities

recommendations B (Evidence levels IIa, IIb, III) Requires availability of well conducted clinical studies but no randomised clinical trials on the topic of recommendation C (evidence level IV) Requires evidence from expert committee reports or opinions and/or clinical experience of respected authorities. Indicates absence of directly applicable studies of good quality. Additional Clinical Considerations & References Where applicable each guideline consists of three broad sections. The first section (...) on integrated care. They target a wide audience and should be made available to all those individuals and groups concerned with the health and welfare of people with learning disabilities. Improvements in oral health care can be obtained by encouraging carers to regularly examine the mouth of the person they are caring for. Completing an oral check (assessment) will help to identify any changes in the mouth and can aid appropriate diagnosis and treatment if reported to the dentist at an early stage

2012 Royal College of Surgeons of England

124. Pharmacokinetics of SAR441236

and/or hospitalization within 45 days prior to entry. Diagnosis of AIDS-defining illness using the current list on the US Centers for Disease Control and Prevention (CDC) website within 1 year prior to entry. Weight greater than 115 kg within 45 days prior to study entry. Exclusion Criteria, Arm A Within 12 months prior to study entry, any plasma HIV-1 RNA above the limit of quantification by any FDA-approved assay on a licensed kit with a limit of quantification less than or equal to 50 copies/mL of plasma (...) is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03705169 Recruitment Status : Not yet recruiting First Posted : October 15, 2018 Last Update Posted : March 1, 2019 See Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Information provided by (Responsible Party

2018 Clinical Trials

125. Effectiveness of innovation grants to smallholder agricultural producers

Agricultural Technology Information and Response Initiative (Kenya) AusAID Australian Government Overseas Aid Program BLDS British Library for Development Studies C3F City-Community Challenge Fund CATF Competitive agricultural technology funds CEDAC Cambodian Center for Study and Development in Agriculture/Centre d’Etude et de Développement Agricole Cambodgien CF Competitive fund(s) CGIAR Consultative Group on International Agricultural Research CIAL Local agricultural research committees CIAT (...) Instrumental variable KARI Kenya Agricultural Research Institute KENFAP Kenya National Federation of Agricultural Producers KIT Royal Tropical Institute, Amsterdam (the Netherlands) KSL KENFAP Services Ltd LEI Agricultural Economics Research Institute (WUR) LIBIRD Local Initiatives for Biodiversity, Research and Development (Nepal) LISF Local innovation support funds (PROLINNOVA) LISP Local Initiatives Support Project (Lesotho) MAAIF Ministry of Agriculture, Animal Industries and Fisheries (Uganda

2013 EPPI Centre

126. Prevention of skin cancer

of possible conflicts of interest German Cancer Aid provided financial resources through the German Guideline Program in Oncology (GGPO). These resources were used for staffing costs, office materials, literature procurement and consensus conferences (room hire, technology, catering, moderator’s fees, travelling expenses of participants). The compilation of the guideline was editorially independent of the funding organisation. All members provided a written disclosure of possible conflicts of interest (...) on the relative risk of developing melanoma 81 Table 31: Algorithm for an “informed decision” 193 © German Guideline Program in Oncology | Evidence-based Guideline on Prevention of Skin Cancer | April 2014 1.1 Editors 7 1. Information about this guideline 1.1. Editors German Guideline Program in Oncology of the Association of Medical Scientific Societies (AWMF), the German Cancer Society (DKG) and German Cancer Aid (DKH). 1.2. Leading professional society Association of Dermatological Prevention (ADP

2014 German Guideline Program in Oncology

127. Treatment and recommendations for homeless people with Opioid Use Disorders

practice adaptations. For most of his career, Jay worked in the human services field, first as an emergency medical technician and then as a social worker for the Massachusetts Department of Mental Health, running dual diagnosis programs dealing with mental illness and addiction therapy. He was also an ardent consumer advocate in campaigns promoting patient safety through the use of medications like naloxone (Narcan®), which can help to prevent opioid overdose deaths. He worked with the Boston Health (...) to promote successful treatment of homeless patients with opioid use disorders: a harm reduction/ low-threshold model of care (Denning & Little 2011, Zevin 2011, Stancliff 2012); explicit overdose prevention and management training and naloxone rescue kit access (Wheeler 2012, Walley 2013); integration of primary care with mental health and addiction services provided by a multidisciplinary clinical team (Meinbresse 2013, Goyer 2011); use of creative outreach strategies and unconventional treatment sites

2014 National Health Care for the Homeless Council

128. Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack Full Text available with Trip Pro

among survivors of ischemic stroke or TIA. The current average annual rate of future stroke (≈3%–4%) represents a historical low that is the result of important discoveries in prevention science. These include antiplatelet therapy and effective strategies for treatment of hypertension, atrial fibrillation (AF), arterial obstruction, and hyperlipidemia. Since the first of these therapies emerged in 1970, when results of the Veterans Administration Cooperative Study Group trial of hypertension therapy (...) with ischemic stroke or TIA who, after the first several days, have an established BP ≥140 mm Hg systolic or ≥90 mm Hg diastolic ( Class I; Level of Evidence B). Initiation of therapy for patients with BP <140 mm Hg systolic and <90 mm Hg diastolic is of uncertain benefit (Class IIb; Level of Evidence C ). Clarification of parameters for initiating BP therapy Resumption of BP therapy is indicated for previously treated patients with known hypertension for both prevention of recurrent stroke and prevention

2014 American Heart Association

129. Venous Legs Ulcers

description and initial questions Questions regarding the diagnostics, the treatment, the follow-up treatment and the organization of care of venous leg ulcers were answered for the purpose of developing the guideline. EDF guidelines leg ulcers / version 4.0 2 Working group The Commission on guidelines of the European Dermatological Federation (EDF) inaugurated the Chairman of the working group on wound healing during its annual meeting in January 2004. This guideline is the first on wound healing (...) 5 EDF Guidelines Subcommittee Identification/nomination of additional 50% EDF members for the EDF-GsubC from amongst the authors of the best guidelines 6 EDF Guidelines Subcommittee Nomination of chairperson for EDF-GSubC from the GSubC members 7 Chairperson Consideration of involvement of other disciplines and patients´ organizations 8 EDF Guidelines Subcommittee Meeting 1.To decide the author of the first draft and to discuss the present guidelines, their strengths and weaknesses 2. Six months

2014 European Dermatology Forum

130. Framework towards tuberculosis elimination in low-incidence countries

such as HIV/AIDS care and treatment and mental health and substance abuse teams. In some low-incidence countries, indigenous populations (e.g. Aboriginal people or First Nations) and certain ethnic minorities (e.g. Roma) have TB incidence rates that are much higher even than those in the general population in high-incidence countries. This can be due to a combination of higher exposure to TB risk factors, poor access to health care and possibly genetic factors (44). Immigrants from high-incidence (...) realization of the dream. Elimination must still be the aim, but the strategies to reach it must take into account all the obstacles to be overcome (9,14,18,20,22,28,30). 3.2 Special challenges for TB care and prevention in low-incidence countries 3.2.1 Concentration in vulnerable groups As TB incidence falls, TB becomes concentrated in certain vulnerable groups, such as the poor, the homeless, migrants, people living with HIV/AIDS, people with harmful alcohol use, illicit drug users, prisoners and other

2014 World Health Organisation Guidelines

131. March 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection

therapy 3. Pharmaceutical equivalence and clinical interchangeability between lamivudine and emtricitabine 4. Use of efavirenz during pregnancy as part of first-line antiretroviral therapy: a public health perspective 5. Optimizing antiretroviral drugs for children: medium- and long-term priorities 6. Changing role of CD4 cell counts in HIV care and treatment 7. Scaling up viral load testing in resource-limited settings Supplementary sections to Chapter 9 – Guidance on operations and service delivery (...) alafenamide fumarate TB tuberculosis TDF tenofovir disoproxil fumarate TEE tenofovir disoproxil fumarate plus emtricitabine plus efavirenz TLE tenofovir disoproxil fumarate plus lamivudine plus efavirenz TNA threose nucleic acid UNAIDS Joint United Nations Programme on HIV/AIDS UNICEF United Nations Children’s Fund XTC 3TC or FTC7 FOREWORD Countries have requested that WHO streamline, in a user- friendly manner, the development and release of HIV-related guidelines and of its technical and programmatic

2014 World Health Organisation HIV Guidelines

132. Framework for conducting reviews of tuberculosis programmes

version of the document and provided significant input. Malgorzata Grzemska and Salah-Eddine Ottmani compiled the comments provided by the reviewers and finalized the document. Development of this document was funded by the Global Fund To Fight AIDS, Tuberculosis and Malaria under the Contribution Agreement between TGF and WHO in 2012 P.O number. 20043877. Photocredit: WHO/Soleil LabelleFramework for conducting reviews of tuberculosis programmes 1 Contents Abbreviations 2 Foreword 3 1 Introduction (...) of the national tuberculosis programme and to be made available to the reviewers 33 Annex 3 Terms of reference for the TB epidemiological and impact analysis component of a national programme review 36 Annex 4 Checklists for assessing selected areas of tuberculosis activities during a review of a national programme 42 Annex 5 Selected references 442 Abbreviations AFB acid-fast bacilli AIDS acquired immunodeficiency syndrome ART antiretroviral treatment BMU Basic Medical Unit CPT co-trimoxazole preventive

2014 World Health Organisation Guidelines

133. Abuse and violence - working with our patients in general practice

in this publication is current at the date of first publication and is intended for use as a guide of a general nature only and may or may not be relevant to particular patients or circumstances. This publication is not exhaustive of the subject matter. Persons implementing any recommendations contained in this publication must exercise their own independent skill or judgement or seek appropriate professional advice relevant to their own particular circumstances. Compliance with any recommendations cannot (...) Australia Tel 1800 626 901 Fax 03 9696 7511 www.racgp.org.au ISBN 978-0-86906-384-2 First edition published 1992 Second edition published 1998 Third edition published 2008 Fourth edition published June 2014 © The Royal Australian College of General Practitioners 2014i Abuse and violence Working with our patients in general practice Abuse and violence Working with our patients in general practice (4th edition)iii Abuse and violence Working with our patients in general practice Acknowledgements

2014 Clinical Practice Guidelines Portal

134. Preserving Patient Dignity (Formerly Patient Modesty) Volume 109

, the medical assistant was unusually casual in performing my workup. She was new and it was the first time I had been attended to by a medical assistant in that practice. As I may have previously posted, she is the one who tried to open my pants for the bladder scan without asking me first. There were a couple of other things she did that were unprofessional and made me feel uncomfortable. Mainly, she was just too familiar and crossed some boundaries. I called her supervisor the next day and complained (...) of the time as I have female doctors, they understand "No" means "No" w/ no explanation being necessary. The times I have gotten pushback are from female nurses. Obviously, they don't know or don't care that a patient $ only a patient only has the right to decide who, what, how, etc happens to their body. I don't feel I owe them an explanation but have retorted back if they think it should happen, then they should be first while I observe to see how it happens as seeing it happen could help change my mind

2020 Bioethics Discussion Blog

135. Assets in Action: Illustrating asset based approaches for health improvement

a range of sources into one central working document, thereby aiding the analysis process. Speci? cally, the framework was used to: classify the data into meaningful categories; rearrange the data into a more manageable form; and develop and verify patterns, relationships and issues from the data. Analysis was carried out within case initially and, subsequently, a thematic across-case analysis was undertaken to synthesise the learning. Analysis was supported by use of Atlas.ti software. Identi? cation

2012 Glasgow Centre for Population Health

136. Treatment and Recommendations for Homeless Patients with Chlamydial or Gonococcal Infections

Websites 38 About the HCH Clinicians’ Network 38Care for Homeless Patients with Chlamydial or Gonococcal Infections: Summary of Recommendations 9 Adults and Adolescents DIAGNOSIS AND EVALUATION History ? Sexual practices Obtain detailed history of sexual practices at first visit. ? Sexual abuse Ask whether patient has been forced to have sexual intercourse against his/her will. ? Exploitation Consider possible exploitation of patient, especially if mental illness or developmental disability (...) CDC recommended first- line treatment regimens calls for single-dose DOT for both chlamydial and gonococcal infections. ? Presumptive treatment Treat patient and partner empirically pending lab results, even if partner is not seen in clinic, if this can be done safely and if regulations/clinic policies permit. ? HBV & HAV Recognize that some homeless people are at high risk for hepatitis B and/or hepatitis A infection. Assure that at-risk patients are immunized. For those who have been partially

2013 National Health Care for the Homeless Council

137. Guidelines for the Clinical and Operational Management of Drug-Resistant Tuberculosis

Paris, France Suggested citation Caminero JA, ed. Guidelines for Clinical and Operational Management of Drug-Resistant Tuberculosis. Paris, France: International Union Against Tuberculosis and Lung Disease, 2013. First published online 22 March 2013; revised 6 May 2013. © International Union Against Tuberculosis and Lung Disease (The Union) 68 boulevard St Michel, 75006 Paris, France March 2013 All rights reserved. No part of this publication may be reproduced without the permission of the authors (...) FDC ? xed-dose combination FLD ? rst-line drug FQ ? uoroquinolone GDF Global Drug Facility GFATM The Global Fund to Fight AIDS, Tuberculosis and Malaria Gfx gati? oxacin GLC Green Light Committee (WHO) H isoniazid HAART highly active antiretroviral therapy HEPA ? lter high-ef? ciency particulate air ? lter HIV human immunode? ciency virus IC infection control ICF intensi? ed case ? nding IPT intermittent preventive treatment Km kanamycin MDR-TB multidrug-resistant tuberculosis; Mycobacterium

2013 International Union Against TB and Lung Disease

138. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection

diagnosed with HIV infection to HIV care and treatment 85 6.1 Introduction 86 6.2 Good practices for linkage to care 86 6.3 General care for people living with HIV 867 Contents Contents 6.4 Preparing people living with HIV for Ar T 89 6.5 What to expect in the first months of A r T 90 7. Clinical guidance across the continuum of care: Antiretroviral therapy 91 7.1 When to start ArT 92 7.1.1 When to start Ar T in adults and adolescents 93 7.1.2 When to start Ar T in pregnant and breastfeeding women 100 (...) 7.1.3 Ar V drugs and duration of breastfeeding 104 7.1.4 When to start Ar T in children 108 7.2 What Ar V regimen to start with (first-line A r T) 112 7.2.1 First-line Ar T for adults 113 7.2.2 First-line Ar T for pregnant and breastfeeding women and Ar V drugs for their infants 116 7.2.3 First-line Ar T for children younger than three years of age 122 7.2.4 First-line Ar T for children three years and older (including adolescents) 126 7.2.5 TB co-treatment in children 130 7.3 Monitoring response

2013 World Health Organisation HIV Guidelines

139. Guidelines for assessing the utility of data from prevention of mother-to-child transmission

FEFO first-to-expire, first-out HIV human immunodeficiency virus HSS HIV sentinel surveillance M&E monitoring and evaluation MCH maternal and child health MOH Ministry of Health PCR polymerase chain reaction PEPFAR the United States President’s Emergency Plan for AIDS Relief PMTCT prevention of mother-to-child transmission QA quality assurance QC quality control SSA sub-Saharan Africa SOP standard operating procedure STI sexually transmitted infection UAT unlinked anonymous testing UNAIDS Joint (...) Guidelines for assessing the utility of data from prevention of mother-to-child transmission For more information, contact: World Health Organization Department of HIV/AIDS Avenue Appia 20 1211 Geneva 27 Switzerland E-mail: hiv-aids@who.int www.who.int/hiv UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance Guidelines for assessing the utility of data from prevention of mother-to-child transmission (PMTCT) programmes for HIV sentinel surveillance among pregnant women ISBN 978 92 4

2013 World Health Organisation HIV Guidelines

140. Guideline on the use of devices for adult male circumcision for HIV prevention

, Namibia), Cynthia Chasokela (Ministry of Health and Child Welfare, Zimbabwe), Dianna Edgil (United States Agency for International Development, USA), Karin Hatzold (PSI, Zimbabwe), Albert Kaonga (Ministry of Health, Zambia), Lija Jackson (Ministry of Health, Tanzania), Edgar Makona* (Global Youth Coalition on HIV/AIDS, Kenya), Marion Natukunda (AIDS Information Center, Uganda), Walter Obiero (Nyanza Reproductive Health Society, Kenya), Dayanund Loykissoonlal (National Department of Health, South (...) Africa), Daniel Makawa (Chipatra General Hospital, Zambia), Dino Rech (Center for HIV and AIDS Prevention Studies, South Africa), Jason Reed (U.S. President’s Emergency Plan for AIDS Relief, USA), Renee Ridzon (Consultant to Bill and Melinda Gates Foundation, USA), Christopher Samkange* (University of Zimbabwe, Zimbabwe), Carl Schutte (Strategic Development Consultants, South Africa), Xaba Sinokuthemba (Ministry of Health and Child Welfare, Zimbabwe), Eugene Zimulinda (Department of Defence, Rwanda

2013 World Health Organisation HIV Guidelines

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>